NCT06000241 is a clinical trial in Bowel Preparation, sponsored by Peking Union Medical College Hospital.

Who is sponsoring NCT06000241?

NCT06000241 is sponsored by Peking Union Medical College Hospital.

What condition does NCT06000241 study?

NCT06000241 studies Bowel Preparation.

Is NCT06000241 still recruiting?

NCT06000241 is currently completed. Last updated 21 August 2023.

Last reviewed 2023-08-21 · How we verify

NCT06000241

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Same Morning vs Previous Evening Dosing Regimen for Assessment of Quality of Bowel Preparation for Colonoscopy Under Anesthesia

Completed Last updated 21 August 2023

What this trial tests

trial in Bowel Preparation in 220 participants. Completed in 1 July 2023.

Timeline

1 January 2021

Primary endpoint
15 June 2023

1 July 2023

Quick facts

Lead sponsor	Peking Union Medical College Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	220
Start date	1 January 2021
Primary completion	15 June 2023
Estimated completion	1 July 2023
Sites	2 locations across China

Conditions studied

Bowel Preparation — all drugs for Bowel Preparation →

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 18 to 80, any sex, with Bowel Preparation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

220 patients are allocated randomly to the morning group (am group) or the afternoon group (pm group) and assessed by quality of bowel preparation and residual volume gastric residue.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bowel Preparation

Currently open trials in the same condition.

NCT06051955 — Evaluation of an Oral Sodium Sulfate Solution for Patients With Prior Difficult or Incomplete Cleansing · NA · recruiting

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06000241 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
Last refreshed: 21 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06000241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing